B-CELL LYMPHOMA
Clinical trials for B-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new B-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for B-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First patients test 'Switchable' Cancer-Fighting cells
Disease control TerminatedThis was the first-ever study in people of a new type of CAR-T cell therapy called ASP2802 for B-cell lymphoma that has come back or not responded to prior treatments. The main goal was to find a safe dose and understand how the body handles the treatment. The study was terminate…
Matched conditions: B-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
CRISPR gene editing used to create 'Ready-Made' cancer therapy
Disease control TerminatedThis study tested a new type of cell therapy called CTX110 for adults with B-cell cancers that have returned or not responded to other treatments. The therapy uses immune cells (T cells) from healthy donors that are modified using CRISPR gene-editing technology to target cancer. …
Matched conditions: B-CELL LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: CRISPR Therapeutics AG • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC